As of 2025-07-08, the EV/EBITDA ratio of Reata Pharmaceuticals Inc (RETA) is -15.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RETA's latest enterprise value is 5,813.45 mil USD. RETA's TTM EBITDA according to its financial statements is -378.12 mil USD. Dividing these 2 quantities gives us the above RETA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.9x | 10.6x |
| Forward P/E multiples | 11.1x - 17.6x | 14.8x |
| Fair Price | (125.23) - (145.50) | (143.70) |
| Upside | -172.7% - -184.4% | -183.4% |
| Date | EV/EBITDA |